A recent objective study has demonstrated that the use of adjuvant platinum-based intraperitoneal chemotherapy in patients with small-volume residual advanced-stage ovarian cancer remains limited, ...
Steady-state levels and bone marrow toxicity of etoposide in children and infants: does etoposide require age-dependent dose calculation? Thirty-three patients with residual ovarian cancer following ...
There are at least eight reasons why the Armstrong article does not support the use of IP administration as a standard of care. Furthermore, more patients in the experimental arm (IP chemotherapy) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results